Michael W Bonney Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

ALNY Quotes by TradingView

Michael W Bonney is Director of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 16,029 shares of ALNY, which is worth approximately $3.9 Million. The most recent transaction as insider was on Dec 27, 2023, when has been sold 30,000 shares (Common Stock) at a price of $195.0 per share, resulting in proceeds of $5,850,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16K
0% 3M change
0% 12M change
Total Value Held $3.9 Million

MICHAEL W BONNEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 27 2023
SELL
Open market or private sale
$5,850,000 $195.0 p/Share
30,000 Reduced 65.18%
16,029 Common Stock
Dec 27 2023
BUY
Exercise of conversion of derivative security
$2,893,500 $96.45 p/Share
30,000 Added 39.46%
46,029 Common Stock
Aug 03 2023
SELL
Open market or private sale
$1,190,945 $184.7 p/Share
6,448 Reduced 28.69%
16,029 Common Stock
Aug 02 2023
BUY
Exercise of conversion of derivative security
-
22,477 Added 50.0%
22,477 Common Stock

Also insider at

BMY
BRISTOL MYERS SQUIBB CO Healthcare
Director
MGTA
Magenta Therapeutics, Inc. Healthcare
Director
KLDO
Kaleido Biosciences, Inc. Healthcare
Director
MWB

Michael W Bonney

Director
New York, NY

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALNY